Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

CD19-positive Relapsed or Refractory B-cell Malignancies × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Multiple Myeloma 19 Lymphoma, Large B-Cell, Diffuse 19 Burkitt Lymphoma 18 Lymphoma 17 Lymphoma, Follicular 14 Neoplasms 13 Leukemia, Myeloid, Acute 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 12 Breast Neoplasms 11 Recurrence 10 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Melanoma 8 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, B-Cell 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Sarcoma 5 Rhabdomyosarcoma 5 Pancreatic Neoplasms 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Sarcoma, Ewing 4 Neuroblastoma 4 Neoplasm Metastasis 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡